A state-of-the-art review on the NRF2 in Hepatitis virus-associated liver cancer

L Kalantari, ZR Ghotbabadi, A Gholipour… - Cell Communication and …, 2023 - Springer
According to a paper released and submitted to WHO by IARC scientists, there would be
905,700 new cases of liver cancer diagnosed globally in 2020, with 830,200 deaths …

HBV infection and host interactions: the role in viral persistence and oncogenesis

R Nevola, D Beccia, V Rosato, R Ruocco… - International Journal of …, 2023 - mdpi.com
Hepatitis B virus (HBV) is a major cause of chronic hepatitis, liver cirrhosis, and
hepatocellular carcinoma. Despite the advent of vaccines and potent antiviral agents able to …

Hijacking and rewiring of host CircRNA/miRNA/mRNA competitive endogenous RNA (ceRNA) regulatory networks by oncoviruses during development of viral …

MJ Kamali, M Salehi, M Mostafavi… - Reviews in medical …, 2024 - Wiley Online Library
A significant portion of human cancers are caused by oncoviruses (12%–25%). Oncoviruses
employ various strategies to promote their replication and induce tumourigenesis in host …

Past, present, and future of chemically induced hepatocarcinogenesis rodent models: Perspectives concerning classic and new cancer hallmarks

GR Romualdo, R Heidor, GP Bacil, FS Moreno… - Life Sciences, 2023 - Elsevier
Hepatocellular carcinoma (HCC), the main primary liver cancer, accounts for 5% of all
incident cases and 8.4% of all cancer-related deaths worldwide. HCC displays a spectrum of …

Protein arginine methyltransferases (PRMTs): Orchestrators of cancer pathogenesis, immunotherapy dynamics, and drug resistance

Y Gao, C Feng, J Ma, Q Yan - Biochemical pharmacology, 2024 - Elsevier
Abstract Protein Arginine Methyltransferases (PRMTs) are a family of enzymes regulating
protein arginine methylation, which is a post-translational modification crucial for various …

Curcumin-loaded pH-sensitive carboxymethyl chitosan nanoparticles for the treatment of liver cancer

X Yang, D Meng, N Jiang, C Wang… - Journal of …, 2024 - Taylor & Francis
In this study, the pH-responsive API-CMCS-SA (ACS) polymeric nanoparticles (NPs) based
on 1-(3-amino-propyl) imidazole (API), stearic acid (SA), and carboxymethyl chitosan …

[HTML][HTML] Precision targeting in hepatocellular carcinoma: Exploring ligand-receptor mediated nanotherapy

XQ Zhou, YP Li, SS Dang - World Journal of Hepatology, 2024 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the most common primary liver cancer and poses a
major challenge to global health due to its high morbidity and mortality. Conventional …

Hepatitis E virus infection and risk of hepatocellular carcinoma: A systematic review and meta-analysis

X Yin, F Kan - Cancer Epidemiology, 2023 - Elsevier
Background The potential role of hepatitis E virus (HEV) infection in developing
hepatocellular carcinoma (HCC) is controversial and poorly investigated. We conducted a …

Hepatitis B Virus and microRNAs: A Bioinformatics Approach

V Zulian, G Fiscon, P Paci, AR Garbuglia - International Journal of …, 2023 - mdpi.com
In recent decades, microRNAs (miRNAs) have emerged as key regulators of gene
expression, and the identification of viral miRNAs (v-miRNAs) within some viruses, including …

Contemporary Insights into Hepatitis C Virus: A Comprehensive Review

M Sallam, R Khalil - Microorganisms, 2024 - mdpi.com
Hepatitis C virus (HCV) remains a significant global health challenge. Approximately 50
million people were living with chronic hepatitis C based on the World Health Organization …